Device Orthodontic Prosthetics

LP and Ifit Tubes

Payments companies reported to CMS as associated with LP and Ifit Tubes. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$1.1Massociated payments (2023-2025)
5,309clinicians with associated payments
1company reporting

By year

2023 $356K
2024 $375K
2025 $419K

Payments reported as associated with LP and Ifit Tubes, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Orthodontics and Dentofacial Orthopedics $1.0M
Dentist $92K
General Practice (Dentist) $23K
Pediatric Dentistry $12K
Oral and Maxillofacial Surgery $2,796
Foot and Ankle Surgery $2,722

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with LP and Ifit Tubes

These are the largest totals companies reported as associated with LP and Ifit Tubes. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Brian Hohlen Omaha, NE Dentist $8,013.95
Martin Gochnour Madison, WI Orthodontics and Dentofacial Orthopedics $7,384.61
James Kolstad Waukesha, WI Orthodontics and Dentofacial Orthopedics $5,869.57
John Pritchett Indianapolis, IN Orthodontics and Dentofacial Orthopedics $5,238.61
Shane Blacker Tempe, AZ Orthodontics and Dentofacial Orthopedics $4,937.82
Wesley Gass Gainesville, GA Orthodontics and Dentofacial Orthopedics $4,598.28
Christian Fortney Escondido, CA Orthodontics and Dentofacial Orthopedics $4,598.10
Shawn O'Bannon Oxford, MS Orthodontics and Dentofacial Orthopedics $4,578.44
Jason Huse St Cloud, MN Orthodontics and Dentofacial Orthopedics $4,445.25
Ethan Just Manitowoc, WI Orthodontics and Dentofacial Orthopedics $4,438.01

Prescribed LP and Ifit Tubes?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.